Sign in or create an account to add this stock to your watchlist.
About Align Technology (NASDAQ:ALGN)
Align Technology, Inc. designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases. It also provides Invisalign Express (10 and 5) and Invisalign Lite/i7 treatments for orthodontic cases, non-comprehensive treatment relapse cases, or straightening prior to restorative or cosmetic treatments; Invisalign Go, a solution for general practitioner dentists (GPs) to identify and treat patients with mild malocclusion; SmileDirectClub aligners for minor tooth movement; custom clear aligner retainers used to maintain tooth position and correct minor relapse; and SmartTrack, a custom-engineered material that delivers force for orthodontic tooth movements. The company's Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; and Restorative software for iTero, a software for GPs, prosthodontists, periodontists, and oral surgeons. It also provides Orthodontic software for iTero, a software for orthodontists for digital records storage, orthodontic diagnosis, Invisalign digital impression submission, and for the fabrication of printed models and retainers; CAD/CAM services, such as iTero Models and Dies, OrthoCAD iCast, and OrthoCAD iRecord; and Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner, as well as third party scanners and digital scans for Invisalign treatment submission. The company was founded in 1997 and is headquartered in San Jose, California.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:ALGN
CUSIP01625510
Phone408-470-1000
Debt
Debt-to-Equity RatioN/A
Current Ratio2.26
Quick Ratio2.19
Price-To-Earnings
Trailing P/E Ratio76.57
Forward P/E Ratio63.65
P/E Growth2.18
Sales & Book Value
Annual Sales$1.47 billion
Price / Sales16.20
Cash Flow$4.4351 per share
Price / Cash67.16
Book Value$14.35 per share
Price / Book20.76
Profitability
EPS (Most Recent Fiscal Year)$3.89
Net Income$231.41 million
Net Margins16.12%
Return on Equity30.36%
Return on Assets20.24%
Miscellaneous
Employees8,715
Outstanding Shares80,150,000
Align Technology (NASDAQ:ALGN) Frequently Asked Questions
What is Align Technology's stock symbol?
Align Technology trades on the NASDAQ under the ticker symbol "ALGN."
How were Align Technology's earnings last quarter?
Align Technology (NASDAQ:ALGN) announced its quarterly earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.98 by $0.19. The medical equipment provider earned $436.92 million during the quarter, compared to analyst estimates of $408.27 million. Align Technology had a return on equity of 30.36% and a net margin of 16.12%. Align Technology's quarterly revenue was up 40.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.59 earnings per share. View Align Technology's Earnings History.
When is Align Technology's next earnings date?
What guidance has Align Technology issued on next quarter's earnings?
Align Technology issued an update on its second quarter earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $1.02-1.06 for the period, compared to the Thomson Reuters consensus estimate of $1.03. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $452.20 million.
What price target have analysts set for ALGN?
15 brokerages have issued 1-year price objectives for Align Technology's stock. Their forecasts range from $150.00 to $350.00. On average, they expect Align Technology's share price to reach $271.20 in the next year. View Analyst Ratings for Align Technology.
What are Wall Street analysts saying about Align Technology stock?
Here are some recent quotes from research analysts about Align Technology stock:
- 1. According to Zacks Investment Research, "Align Technology started off 2018 on a solid note. We are optimistic about the continued strength in Invisalign volumes. The company’s solid Invisalign Technology prospects and growth in North America and internationally, particularly in the Asia-Pacific and EMEA regions, also raise optimism. The strong uptake of iTero scanners across all geographies is impressive as well. Further, Align Technology’s receipt of CFDA approval to commercially launch the iTero Element intraoral scanner in China buoys optimism. We are also upbeat about the company expanding the iTero Element portfolio with the launch of iTero Element 2 and iTero Element Flex scanners. On the flip side, adverse foreign currency fluctuation is a concern. Moreover, tough competition, rising operating costs and macroeconomic headwinds continue to weigh on the stock. Over the past month, Align Technology has been underperforming its industry." (5/15/2018)
- 2. Leerink Swann analysts commented, "healthy" (6/26/2017)
Who are some of Align Technology's key competitors?
Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Coloplast (CLPBY), Smith & Nephew (SNN), William Demant (WILYY), STERIS (STE), Inogen (INGN), Mine Safety Appliances (MSA), Wright Medical Group (WMGI), Halyard Health (HYH), Consort Medical (CSRMY), Invacare (IVC), Sientra (SIEN) and RTI Surgical (RTIX).
Who are Align Technology's key executives?
Align Technology's management team includes the folowing people:
- Mr. Joseph M. Hogan, Pres, CEO & Director (Age 61)
- Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 51)
- Mr. Emory M. Wright, Sr. VP of Global Operations (Age 48)
- Mr. Zelko Relic, CTO and Sr. VP of Global R&D (Age 53)
- Mr. Raphael S. Pascaud, Chief Marketing Portfolio & Bus. Devel. Officer and Sr. VP of iTero Scanner & Services (Age 46)
Has Align Technology been receiving favorable news coverage?
Headlines about ALGN stock have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Align Technology earned a daily sentiment score of 0.16 on Accern's scale. They also gave news coverage about the medical equipment provider an impact score of 46.77 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
Who are Align Technology's major shareholders?
Align Technology's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.32%), Polen Capital Management LLC (3.33%), Disciplined Growth Investors Inc. MN (1.20%), Old Mutual Global Investors UK Ltd. (0.90%), Federated Investors Inc. PA (0.72%) and Victory Capital Management Inc. (0.61%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Emory Wright, George J Morrow, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Thomas M Prescott, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.
Which institutional investors are selling Align Technology stock?
ALGN stock was sold by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., Fiera Capital Corp, Victory Capital Management Inc., Ownership Capital B.V., Smith Asset Management Group LP, Frontier Capital Management Co. LLC, BlackRock Inc. and Sei Investments Co.. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Emory Wright, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli and Thomas M Prescott. View Insider Buying and Selling for Align Technology.
Which institutional investors are buying Align Technology stock?
ALGN stock was purchased by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, TCW Group Inc., Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, Prudential Financial Inc., Carillon Tower Advisers Inc., Polen Capital Management LLC and Motley Fool Asset Management LLC. View Insider Buying and Selling for Align Technology.
How do I buy shares of Align Technology?
Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Align Technology's stock price today?
One share of ALGN stock can currently be purchased for approximately $297.86.
How big of a company is Align Technology?
Align Technology has a market capitalization of $23.88 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.
How can I contact Align Technology?
Align Technology's mailing address is 2560 ORCHARD PARKWAY, SAN JOSE CA, 95131. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]
MarketBeat Community Rating for Align Technology (ALGN)
MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe ALGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Align Technology (NASDAQ:ALGN) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
15 Wall Street analysts have issued ratings and price targets for Align Technology in the last 12 months. Their average twelve-month price target is $271.20, suggesting that the stock has a possible downside of 8.95%. The high price target for ALGN is $350.00 and the low price target for ALGN is $150.00. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.80 | 2.79 | 2.83 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
3 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $271.20 | $254.1429 | $253.5833 | $222.40 |
| Price Target Upside: | 8.95% downside | 0.54% upside | 3.21% downside | 12.96% downside |
Align Technology (NASDAQ:ALGN) Consensus Price Target History
Align Technology (NASDAQ:ALGN) Analyst Ratings History
Show:
(Data available from 5/23/2016 forward)
Align Technology (NASDAQ:ALGN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Align Technology (NASDAQ ALGN) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.40%
Institutional Ownership Percentage: 78.38%
Align Technology (NASDAQ ALGN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/21/2018 | Julie Tay | SVP | Sell | 4,440 | $300.00 | $1,332,000.00 | 13,176 |  |
| 5/14/2018 | Joseph Lacob | Director | Sell | 20,000 | $289.41 | $5,788,200.00 | | |
| 5/11/2018 | Joseph Lacob | Director | Sell | 10,000 | $285.82 | $2,858,200.00 | | |
| 5/11/2018 | Julie Tay | SVP | Sell | 2,250 | $285.00 | $641,250.00 | 17,616 | |
| 5/7/2018 | C Raymond Larkin Jr | Director | Sell | 15,000 | $264.45 | $3,966,750.00 | 97,922 | |
| 5/7/2018 | Emory Wright | SVP | Sell | 27,492 | $263.68 | $7,249,090.56 | 5,424 | |
| 4/30/2018 | Thomas M Prescott | Director | Sell | 82,000 | $252.75 | $20,725,500.00 | 222,399 | |
| 2/13/2018 | Joseph M Hogan | Insider | Buy | 1,500 | $233.63 | $350,445.00 | 42,984 | |
| 2/2/2018 | Emory Wright | VP | Sell | 45,780 | $260.08 | $11,906,462.40 | 29,957 | |
| 11/30/2017 | Joseph Lacob | Director | Sell | 29,724 | $260.91 | $7,755,288.84 | | |
| 11/28/2017 | Emory Wright | VP | Sell | 5,025 | $263.68 | $1,324,992.00 | 80,762 | |
| 11/24/2017 | John Morici | CFO | Sell | 1,500 | $255.00 | $382,500.00 | 1,544 | |
| 11/13/2017 | Julie Tay | VP | Sell | 3,500 | $253.00 | $885,500.00 | 12,213 | |
| 11/3/2017 | Raphael Pascaud | CMO | Sell | 5,400 | $241.88 | $1,306,152.00 | 22,228 | |
| 10/31/2017 | Greg J Santora | Director | Sell | 7,700 | $238.95 | $1,839,915.00 | | |
| 5/31/2017 | Joseph Lacob | Director | Sell | 50,000 | $144.98 | $7,249,000.00 | | |
| 5/30/2017 | Joseph Lacob | Director | Sell | 3,874 | $143.96 | $557,701.04 | | |
| 5/30/2017 | Sreelakshmi Kolli | VP | Sell | 1,000 | $144.00 | $144,000.00 | 23,785 | |
| 2/28/2017 | Joseph Lacob | Director | Sell | 50,000 | $102.67 | $5,133,500.00 | | |
| 2/24/2017 | Christopher C Puco | VP | Sell | 24,353 | $101.88 | $2,481,083.64 | 19,691 | |
| 2/22/2017 | Thomas M Prescott | Director | Sell | 66,528 | $101.12 | $6,727,311.36 | 272,253 | |
| 2/15/2017 | Andrea Lynn Saia | Director | Sell | 4,000 | $99.68 | $398,720.00 | 14,133 | |
| 2/3/2017 | C Raymond Larkin Jr | Director | Sell | 15,000 | $94.71 | $1,420,650.00 | 92,012 | |
| 11/29/2016 | Jennifer Olson | VP | Sell | 3,662 | $95.44 | $349,501.28 | 8,145 | |
| 11/29/2016 | Warren S Thaler | Director | Sell | 8,500 | $95.57 | $812,345.00 | 42,400 | |
| 11/18/2016 | David L White | CFO | Sell | 11,152 | $95.53 | $1,065,350.56 | 9,473 | |
| 11/14/2016 | Thomas M Prescott | Director | Sell | 33,125 | $90.60 | $3,001,125.00 | 124,378 | |
| 8/29/2016 | Jennifer Olson | VP | Sell | 799 | $93.30 | $74,546.70 | 4,483 | |
| 8/15/2016 | Zelko Relic | VP | Sell | 13,577 | $95.91 | $1,302,170.07 | 1,375 | |
| 8/9/2016 | Julie Tay | VP | Sell | 3,000 | $92.60 | $277,800.00 | 3,104 | |
| 5/23/2016 | George J Morrow | Director | Sell | 50,000 | $77.72 | $3,886,000.00 | 56,400 | |
| 5/16/2016 | Raphael Pascaud | VP | Sell | 3,000 | $77.00 | $231,000.00 | 5,887 | |
| 5/10/2016 | Julie Tay | VP | Sell | 1,250 | $77.00 | $96,250.00 | 6,104 | |
| 5/5/2016 | C Raymond Larkin Jr | Director | Sell | 15,000 | $74.36 | $1,115,400.00 | 85,260 | |
| 5/5/2016 | Roger E George | VP | Sell | 27,311 | $75.00 | $2,048,325.00 | 27,986 | |
| 5/3/2016 | Julie Tay | VP | Sell | 1,754 | $75.00 | $131,550.00 | 7,354 | |
| 5/3/2016 | Thomas M Prescott | Director | Sell | 64,773 | $74.54 | $4,828,179.42 | 111,253 | |
| 2/25/2016 | Christopher C Puco | VP | Sell | 11,413 | $63.51 | $724,839.63 | 4,528 | |
| 2/23/2016 | Timothy A. Mack | VP | Sell | 28,384 | $63.25 | $1,795,288.00 | | |
| 2/22/2016 | Christopher C. Puco | VP | Sell | 6,278 | $64.01 | $401,854.78 | | |
| 2/4/2016 | Greg J Santora | Director | Sell | 9,000 | $67.28 | $605,520.00 | | |
| 1/5/2016 | David C Nagel | Director | Sell | 1,100 | $64.64 | $71,104.00 | 24,700 | |
| 12/14/2015 | David C Nagel | Director | Sell | 1,100 | $65.20 | $71,720.00 | 25,800 | |
| 11/2/2015 | Julie Tay | VP | Sell | 1,500 | $66.67 | $100,005.00 | 500 | |
| 10/30/2015 | Emory Wright | VP | Sell | 25,272 | $65.04 | $1,643,690.88 | 29,719 | |
| 10/28/2015 | Jennifer Erfurth | VP | Sell | 6,198 | $66.04 | $409,315.92 | 686 | |
| 10/27/2015 | David L. White | CFO | Sell | 8,426 | $66.85 | $563,278.10 | 5,636 | |
| 10/27/2015 | Greg J. Santora | Director | Sell | 20,000 | $66.95 | $1,339,000.00 | 35,900 | |
| 8/25/2015 | Andrea Lynn Saia | Director | Sell | 3,567 | $55.10 | $196,541.70 | 9,067 | |
| 8/20/2015 | Warren S. Thaler | Director | Sell | 7,000 | $58.75 | $411,250.00 | 53,100 | |
| 8/17/2015 | Thomas M Prescott | Director | Sell | 40,000 | $60.50 | $2,420,000.00 | | |
| 5/15/2015 | Jennifer Erfurth | VP | Sell | 2,400 | $59.27 | $142,248.00 | | |
| 5/7/2015 | C Raymond Larkin Jr | Director | Sell | 15,000 | $59.03 | $885,450.00 | | |
| 5/6/2015 | Warren S Thaler | Director | Sell | 7,000 | $58.75 | $411,250.00 | | |
| 5/5/2015 | David L White | CFO | Sell | 1,899 | $59.37 | $112,743.63 | | |
| 5/5/2015 | John Patrick Graham | CMO | Sell | 1,139 | $60.37 | $68,761.43 | | |
| 5/5/2015 | Timothy A Mack | VP | Sell | 28,280 | $59.47 | $1,681,811.60 | | |
| 5/1/2015 | Roger E George | VP | Sell | 23,248 | $58.69 | $1,364,425.12 | | |
| 2/26/2015 | Raphael Pascaud | VP | Sell | 6,500 | $56.40 | $366,600.00 | | |
| 2/24/2015 | Christopher C Puco | VP | Sell | 11,982 | $56.40 | $675,784.80 | | |
| 11/4/2014 | Timothy A Mack | VP | Sell | 9,375 | $52.17 | $489,093.75 | | |
| 10/28/2014 | C Raymond Larkin Jr | Director | Sell | 15,000 | $51.54 | $773,100.00 | | |
| 10/28/2014 | Jennifer Erfurth | VP | Sell | 6,242 | $52.25 | $326,144.50 | | |
| 8/27/2014 | Roger E George | VP | Sell | 10,875 | $55.85 | $607,368.75 | | |
| 8/21/2014 | David L White | CFO | Sell | 4,600 | $54.42 | $250,332.00 | | |
| 8/21/2014 | John Patrick Graham | CMO | Sell | 7,046 | $54.41 | $383,372.86 | | |
| 8/19/2014 | Thomas M Prescott | CEO | Sell | 14,896 | $55.07 | $820,322.72 | | |
| 5/29/2014 | Timothy A Mack | VP | Sell | 16,333 | $55.06 | $899,294.98 | | |
| 5/1/2014 | Raphael Pascaud | VP | Sell | 2,000 | $50.79 | $101,580.00 | 105 | |
| 2/25/2014 | Christopher Puco | VP | Sell | 4,462 | $54.09 | $241,349.58 | | |
| 2/24/2014 | Roger George | VP | Sell | 19,474 | $54.23 | $1,056,075.02 | | |
| 2/11/2014 | Jennifer Erfurth | VP | Sell | 3,144 | $55.34 | $173,988.96 | | |
| 2/7/2014 | Thomas Prescott | CEO | Sell | 236,979 | $54.64 | $12,948,532.56 | 171,995 | |
| 2/4/2014 | Timothy Mack | VP | Sell | 12,761 | $54.73 | $698,409.53 | 67 | |
| 2/4/2014 | Warren Thaler | Director | Sell | 18,000 | $54.75 | $985,500.00 | 33,900 | |
| 10/31/2013 | Jennifer Erfurth | VP | Sell | 3,242 | $56.97 | $184,696.74 | | |
| 10/30/2013 | Richard M.L. Twomey | VP | Sell | 4,010 | $57.05 | $228,770.50 | | |
| 10/30/2013 | Thomas M Prescott | CEO | Sell | 188,176 | $56.88 | $10,703,450.88 | | |
| 10/30/2013 | Warren S Thaler | Director | Sell | 35,250 | $56.55 | $1,993,387.50 | | |
| 10/22/2013 | George J Morrow | Director | Sell | 75,000 | $57.27 | $4,295,250.00 | | |
| 10/22/2013 | Thomas M Prescott | CEO | Sell | 74,513 | $58.00 | $4,321,754.00 | | |
| 8/29/2013 | Richard M.L. Twomey | VP | Sell | 2,135 | $43.76 | $93,427.60 | 4,272 | |
| 8/29/2013 | Timothy Mack | SVP | Sell | 18,477 | $43.32 | $800,423.64 | 3,386 | |
| 8/9/2013 | Joseph Lacob | Director | Sell | 8,000 | $43.85 | $350,800.00 | | |
| 8/1/2013 | Greg Santora | Director | Sell | 16,000 | $43.79 | $700,640.00 | 22,700 | |
| 7/30/2013 | Warren S Thaler | Director | Sell | 10,000 | $42.24 | $422,400.00 | | |
| 7/25/2013 | Roger E George | VP | Sell | 26,252 | $43.55 | $1,143,274.60 | | |
| 7/24/2013 | Richard M.L. Twomey | VP | Sell | 4,532 | $43.42 | $196,779.44 | | |
| 5/31/2013 | Joseph Lacob | Director | Sell | 49,998 | $36.16 | $1,807,927.68 | | |
| 5/15/2013 | Richard M.L. Twomey | VP | Sell | 1,875 | $36.10 | $67,687.50 | | |
| 2/4/2013 | Len Hedge | SVP | Sell | 100,000 | $31.38 | $3,138,000.00 | | |
| 11/12/2012 | Dan Scott Ellis | VP | Sell | 18,815 | $26.52 | $498,973.80 | | |
| 8/9/2012 | Joseph Lacob | Director | Sell | 300,000 | $34.97 | $10,491,000.00 | | |
(Data available from 1/1/2013 forward)
Align Technology (NASDAQ ALGN) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Insider Selling: Align Technology (ALGN) SVP Sells 4,440 Shares of Stock
www.americanbankingnews.com - May 22 at 7:10 PM |
 | Nasdaq 100 Movers: BMRN, MU
www.nasdaq.com - May 22 at 3:49 PM |
| Stifel Nicolaus Increases Align Technology (ALGN) Price Target to $350.00
www.americanbankingnews.com - May 22 at 12:54 PM |
 | Align Technology Reaches Analyst Target Price
www.forbes.com - May 21 at 11:58 AM |
| Barclays Boosts Align Technology (ALGN) Price Target to $325.00
www.americanbankingnews.com - May 21 at 11:03 AM |
| Analysts Expect Align Technology (ALGN) Will Post Quarterly Sales of $467.88 Million
www.americanbankingnews.com - May 21 at 2:48 AM |
| Analysts Anticipate Align Technology (ALGN) to Post $1.06 Earnings Per Share
www.americanbankingnews.com - May 19 at 3:16 PM |
| Align Technology (ALGN) Receives New Coverage from Analysts at Evercore ISI
www.americanbankingnews.com - May 16 at 5:31 PM |
| Zacks Investment Research Lowers Align Technology (ALGN) to Hold
www.americanbankingnews.com - May 15 at 1:08 PM |
 | Jim Cramer Weighs In On Align Technology, Berkshire Hathaway, Symantec And More
finance.yahoo.com - May 15 at 11:05 AM |
| Q2 2019 EPS Estimates for Align Technology (ALGN) Lowered by Analyst
www.americanbankingnews.com - May 15 at 8:16 AM |
| Align Technology (ALGN) SVP Julie Tay Sells 2,250 Shares
www.americanbankingnews.com - May 14 at 7:40 PM |
| Align Technology (ALGN) Director Sells $5,788,200.00 in Stock
www.americanbankingnews.com - May 14 at 7:28 PM |
| Align Technology (ALGN) Director Sells $2,858,200.00 in Stock
www.americanbankingnews.com - May 14 at 7:26 PM |
| Noteworthy Monday Option Activity: XRX, ALGN, AMGN
www.nasdaq.com - May 14 at 3:46 PM |
 | Breakout Alert: Align Technology, Inc. Stock Is on the Verge of Big Rally
investorplace.com - May 14 at 12:27 PM |
 | 3Shape Files US Patent Infringement Complaint Against Align Technology
www.bloomberg.com - May 11 at 3:54 PM |
| Align Technology (ALGN) versus Consort Medical (CSRMY) Critical Contrast
www.americanbankingnews.com - May 11 at 11:31 AM |
| Emory Wright Sells 27,492 Shares of Align Technology (ALGN) Stock
www.americanbankingnews.com - May 8 at 7:20 PM |
| Insider Selling: Align Technology (ALGN) Director Sells 15,000 Shares of Stock
www.americanbankingnews.com - May 8 at 7:20 PM |
| Align Technology (ALGN) Upgraded at BidaskClub
www.americanbankingnews.com - May 8 at 11:02 AM |
| Will Dentsply Sirona Beat Analysts’ Revenue Estimates in 1Q18?
finance.yahoo.com - May 4 at 3:49 PM |
| 3 Growth Stocks I'm Holding Onto No Matter How Bumpy the Market Gets
finance.yahoo.com - May 4 at 10:11 AM |
| Analysts Cut Their Targets for XRAY ahead of Its 1Q18 Results
finance.yahoo.com - May 4 at 10:11 AM |
| Align Technology (ALGN) Expected to Post Quarterly Sales of $467.88 Million
www.americanbankingnews.com - May 4 at 4:37 AM |
| Align Technology (ALGN) Upgraded by ValuEngine to "Strong-Buy"
www.americanbankingnews.com - May 4 at 12:54 AM |
 | Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year?
www.zacks.com - May 3 at 3:45 PM |
| These 5 stocks offer a great balance between the growth of tech and the stability of health care
finance.yahoo.com - May 3 at 10:12 AM |
| Lakeland Industries (LAKE) versus Align Technology (ALGN) Critical Review
www.americanbankingnews.com - May 3 at 3:08 AM |
| Bracing For Competition? Cheaper Challengers Enter Invisalign's $1.5 Billion Market
www.forbes.com - May 2 at 10:16 AM |
| Align Technology (ALGN) Expected to Announce Earnings of $1.06 Per Share
www.americanbankingnews.com - May 2 at 3:18 AM |
| Thomas M. Prescott Sells 82,000 Shares of Align Technology (ALGN) Stock
www.americanbankingnews.com - May 1 at 7:20 PM |
| Align Technology Inc Keeps on Rising After Earnings
investorplace.com - May 1 at 1:48 PM |
| Edited Transcript of ALGN earnings conference call or presentation 25-Apr-18 8:30pm GMT
finance.yahoo.com - April 30 at 3:45 PM |
| Align Technology (ALGN) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 30 at 11:41 AM |
| Q1 2019 EPS Estimates for Align Technology (ALGN) Increased by Analyst
www.americanbankingnews.com - April 30 at 4:20 AM |
| Northcoast Research Weighs in on Align Technology's Q1 2019 Earnings (ALGN)
www.americanbankingnews.com - April 30 at 4:20 AM |
| Jefferies Group Weighs in on Align Technology's Q3 2018 Earnings (ALGN)
www.americanbankingnews.com - April 30 at 3:25 AM |
| Q3 2018 Earnings Forecast for Align Technology (ALGN) Issued By Leerink Swann
www.americanbankingnews.com - April 30 at 3:24 AM |
| Align Technology (ALGN) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 29 at 1:18 AM |
| Analyzing Align Technology’s Geographical Performance in 1Q18
finance.yahoo.com - April 27 at 11:01 AM |
| Why Align Technology’s Teen Market Growth Is Accelerating
finance.yahoo.com - April 27 at 11:01 AM |
| Align Technology Stock Rose 5% after Beating 1Q18 Expectations
finance.yahoo.com - April 27 at 11:01 AM |
| What’s Align Technology’s Guidance for 2018?
finance.yahoo.com - April 27 at 11:01 AM |
| Align’s iTero Scanner Business Saw Strong Momentum in 1Q18
finance.yahoo.com - April 27 at 11:01 AM |
| How Align’s Sales and Marketing Initiatives Are Driving Growth
finance.yahoo.com - April 27 at 11:01 AM |
| Q3 2018 EPS Estimates for Align Technology (ALGN) Raised by Analyst
www.americanbankingnews.com - April 27 at 8:54 AM |
| Equities Analysts Set Expectations for Align Technology's Q2 2018 Earnings (ALGN)
www.americanbankingnews.com - April 27 at 8:45 AM |
 | BRIEF-Align Technology Q1 Earnings Per Share $1.17
www.reuters.com - April 26 at 3:45 PM |
| BRIEF-Align Technology Announces China FDA Approval For The Itero Element Intraoral Scanner
www.reuters.com - April 26 at 3:45 PM |
Align Technology (NASDAQ:ALGN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Align Technology (NASDAQ:ALGN) Income Statement, Balance Sheet and Cash Flow Statement
Align Technology (NASDAQ ALGN) Stock Chart for Wednesday, May, 23, 2018
Loading chart…
